Free Trial

Bicara Therapeutics (BCAX) Insider Trading & Ownership

Bicara Therapeutics logo
$21.68 0.00 (0.00%)
Closing price 05/22/2026 04:00 PM Eastern
Extended Trading
$21.71 +0.03 (+0.14%)
As of 05/22/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Bicara Therapeutics (NASDAQ:BCAX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
15.50%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
4
Amount Of
Insider Selling
(Last 12 Months)
$8.18M
Get BCAX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Bicara Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BCAX Insider Buying and Selling by Quarter

Bicara Therapeutics Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/15/2026Sell12,500$20.29$253,625.00  
4/27/2026Sell5,500$22.88$125,840.00  
4/21/2026Sell9,200$23.00$211,600.00  
4/20/2026Sell15,000$23.61$354,150.00  
4/15/2026Sell12,500$23.01$287,625.00  
3/23/2026Sell9,200$18.52$170,384.00  
3/20/2026Sell1,596$18.95$30,244.20  
3/19/2026Sell6,905$18.78$129,675.90  
3/18/2026Sell6,499$18.84$122,441.16  
3/16/2026Sell12,500$19.66$245,750.00  
The SpaceX supplier that shipped 5 billion chips to Starlink (Ad)

When Nvidia surged 770%, its data center cooling supplier Vertiv climbed 1,700%. When Apple ran 2,000%, supplier Broadcom gained 15,000%. The pattern is clear: suppliers often dwarf the headline stock. One little-known company has shipped over 5 billion chips to SpaceX - a figure expected to reach 10 billion by 2027. SpaceX calls them 'instrumental to Starlink's success.' With the IPO expected in June, you can get the name, ticker, and a full year of tech research for just $19 - 85% off.tc pixel

Get the name and ticker before the SpaceX IPO arrives
3/9/2026Sell36,766$19.17$704,804.22  
3/6/2026Sell3,817$18.75$71,568.75  
3/5/2026Sell1,786$18.74$33,469.64  
3/4/2026Sell2,631$18.73$49,278.63  
3/4/2026Sell16,300$18.52$301,876.00  
3/4/2026Sell2,963$18.25$54,074.75  
3/3/2026Sell200$18.45$3,690.00  
3/3/2026Sell13,555$18.22$246,972.10  
3/3/2026Sell17,392$18.16$315,838.72  
1/22/2026Sell1,882$18.15$34,158.30  
1/22/2026Sell3,828$18.10$69,286.80  
1/15/2026Sell149$18.02$2,684.98  
12/15/2025Sell12,500$18.68$233,500.00  
11/24/2025Sell41,163$18.86$776,334.18  
11/24/2025Sell5,500$18.45$101,475.00  
11/24/2025Sell17,795$18.55$330,097.25  
11/21/2025Sell605$18.15$10,980.75  
11/21/2025Sell12,500$18.05$225,625.00  
10/15/2025Sell13,289$18.84$250,364.76  
10/15/2025Sell12,500$18.16$227,000.00  
10/13/2025Sell11,445$18.92$216,539.40  
10/9/2025Sell22,000$18.45$405,900.00  
10/9/2025Sell6,415$18.23$116,945.45  
10/8/2025Sell5,627$18.21$102,467.67  
10/7/2025Sell18,244$18.22$332,405.68  
10/7/2025Sell10,900$18.06$196,854.00  
10/6/2025Sell6,514$18.17$118,359.38  
10/6/2025Sell39,600$18.06$715,176.00  
(Data available from 1/1/2013 forward)

BCAX Insider Trading Activity - Frequently Asked Questions

The list of insiders at Bicara Therapeutics includes Claire Mazumdar, David Raben, Ivan Hyep, James E Flynn, Ra Capital Management, L.P., and Ryan Cohlhepp. Learn more on insiders at BCAX.

15.50% of Bicara Therapeutics stock is owned by insiders. Learn more on BCAX's insider holdings.

The following insiders have purchased BCAX shares in the last 24 months: James E Flynn ($1,260,000.00), and Ra Capital Management, L.P. ($32,994,000.00).

Insiders have purchased a total of 1,903,000 BCAX shares in the last 24 months for a total of $34,254,000.00 bought.

The following insiders have sold BCAX shares in the last 24 months: Claire Mazumdar ($2,738,870.84), David Raben ($938,781.00), Ivan Hyep ($1,728,445.33), and Ryan Cohlhepp ($2,772,965.50).

Insiders have sold a total of 429,266 Bicara Therapeutics shares in the last 24 months for a total of $8,179,062.67 sold.



This page (NASDAQ:BCAX) was last updated on 5/26/2026 by MarketBeat.com Staff.
From Our Partners